Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06565065 · ClinicalTrials.gov registry record · NA

ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study

A NA study of Healthy, sponsored by Western University of Health Sciences.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT06565065: Recruiting NA study of Healthy, sponsored by Western University of Health Sciences.

NCT06565065 is a NA study of Healthy that is actively recruiting participants, run by Western University of Health Sciences. The registered enrollment target is 30 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06565065, a NA study of Healthy, is actively recruiting participants, sponsored by Western University of Health Sciences.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to determine whether osteopathic manipulative treatment (OMT) enhances immune system readiness in healthy adults compared to exercise or sham light treatment. Specifically, the goal of this study is to assess circulating immune cells and signaling molecules in the blood in response to these various treatments. It aims to compare: Complete Blood Counts (CBC) and blood immune signaling molecule levels in healthy adults in response to OMT, sham light touch, and exercise, with measurements taken at multiple time points. Researchers will compare immune blood cells and signaling molecules in response to OMT versus sham light touch and exercise within the same group of healthy adults measured at three time points for each of the three total visits. Participants will do a 15-minute OMT session, a 15-minute light sham session, or a 15-minute exercise session at each of their three separate visits (they will do one of each over the course of their 3 appointments in random order). They will have three blood draws taken at each of those three visits. They will also fill out a Global Physical Activity Questionnaire (GPAQ) survey to assess their level of physical activity throughout the study.

Primary Outcome

CBC with differential will be evaluated to identify the number of circulating plasma leukocytes for each intervention for each of the three interventions at three time points for each visit/intervention. This test will help us identify levels of erythrocytes, platelets, and leukocytes, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. This will be compared across time points for OMT, sham treatment, and exercise.

Conditions Studied

Interventions

  • PROCEDURE Osteopathic Manipulative Treatment (OMT)
  • OTHER Sham Light Touch
  • OTHER Exercise Protocol

Study Locations (2)

California

  • Western University of Health Sciences - Pomona
  • Western University of Health Sciences - Pomona

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-07-14
Est. Completion 2025-12-30
Phase NA

What NCT06565065 shows while recruiting

NCT06565065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Osteopathic Manipulative Treatment (OMT) is the first listed.

NCT06565065 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06565065 about?

NCT06565065 is a clinical study titled "ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study". The goal of this clinical trial is to determine whether osteopathic manipulative treatment (OMT) enhances immune system readiness in healthy adults compared to exercise or sham light treatment. Specifically, the goal of this study is to assess circulating immune cells and signaling molecules in the ...

What is the current status of trial NCT06565065?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-07-14. Estimated completion is 2025-12-30.

What conditions does trial NCT06565065 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06565065?

The interventions under investigation include: Osteopathic Manipulative Treatment (OMT) (PROCEDURE), Sham Light Touch (OTHER), Exercise Protocol (OTHER).

Who is sponsoring clinical trial NCT06565065?

This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06565065 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06565065's enrollment target sits among peer trials

30 678th of 1090 higher than 363 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06565065, the US trial registry maintained by the National Library of Medicine. NCT06565065 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.